FolioLanternBeta
JAZZJazz Pharmaceuticals plc

Mark Smith

Director at Jazz Pharmaceuticals plc, as of Sep 2, 2026Sold $267K of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
9.6K
shares held after the latest filing, Jazz Pharmaceuticals plc
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1.2K
shares sold, past 12 months
1
days with sales
$267K
largest single day, Jun 15, 2026
1
company filed for

Share of stake sold at Jazz Pharmaceuticals plc is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJun 2026: $267K under a disclosed plan$267KJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Jazz Pharmaceuticals plc (JAZZ)DirectorMar 1, 2021Sep 2, 2026

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.